Thonzylamine
![]()  | |
| Clinical data | |
|---|---|
| Other names | Neohetramine | 
| AHFS/Drugs.com | International Drug Names | 
| ATC code | |
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
  | 
| UNII | |
| KEGG | 
  | 
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.001.913 | 
| Chemical and physical data | |
| Formula | C16H22N4O | 
| Molar mass | 286.379 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
|   | |
Thonzylamine (or neohetramine)[1] is an antihistamine and anticholinergic used as an antipruritic.
Synthesis

Thonzylamine synthesis: H. L. Friedman and A, V. Tolstouhov, U.S. patent 2,465,865 (1949).
See also
References
| Antihistamines for topical use | |
|---|---|
| Anesthetics for topical use | |
| Others | 
  | 
Decongestants and other nasal preparations (R01)  | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical | 
  | ||||||||||
| Systemic use: Sympathomimetics  | |||||||||||
  | |||||||||||
| Benzimidazoles (*) | |
|---|---|
| Diarylmethanes | 
 
 
  | 
| Ethylenediamines | |
| Tricyclics | |
| Others | 
  | 
| For topical use | |
Histamine receptor modulators  | |||||
|---|---|---|---|---|---|
| H1 | 
  | ||||
| H2 | 
  | ||||
| H3 | 
  | ||||
| H4 | 
  | ||||
  | |||||
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
